Please assess the completion status of the following clinical trial:

Trial Title: rTMS as a Probe of Episodic Memory Neurocircuitry in Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~1. Between 18 and 40 years of age~2. Within 10 years of illness onset as defined by entry into treatment for psychotic symptoms~3. Able to give informed consent~4. Willing and able to adhere to the study schedule~5. Structured Clinical Interview for DSM-5 (SCID-5) diagnosis of schizophrenia~6. Clinical stability defined by:~   1. Subjects must not have experienced an exacerbation of their illness within 4 weeks prior to randomization, leading to an intensification of psychiatric care in the opinion of the investigator. Examples of intensification of care include, but are not limited to: inpatient hospitalization, day/partial hospitalization, outpatient crisis management, or psychiatric treatment in an emergency room AND~  2. Antipsychotic treatment stability for at least 4 weeks prior to randomization (no change in antipsychotic dosing or addition of new antipsychotic medication)~Exclusion Criteria:~1. Lifetime history of a seizure, excluding febrile seizures and those induced by substance withdrawal~2. First degree relative with idiopathic epilepsy or other seizure disorder~3. History of significant neurological illness~4. History of head trauma as defined by a loss of consciousness or a post-concussive syndrome~5. Pregnant or breast feeding~6. Known intelligence quotient (IQ) \< 70 based on subject report~7. Current acute, serious, or unstable medical conditions~8. Metallic objects planted in or near the head, including implanted pacemaker, medication pump, vagal stimulator, deep brain stimulator, Transcutaneous Electrical Nerve Stimulation (TENS) unit, ventriculoperitoneal shunt, or cochlear implants~9. Contraindications to Magnetic Resonance Imaging (MRI) or otherwise unable to tolerate MRI procedures~10. History of electroconvulsive therapy~11. Subjects taking clozapine~12. Subjects who have participated in a clinical trial with any pharmacological treatment intervention for which they received study-related medication in the 4 weeks prior to randomization~13. Subjects considered a high risk for suicidal acts - active suicidal ideation as determined by clinical interview OR any suicide attempt in 90 days prior to screening~14. Current DSM-5 diagnosis of alcohol or drug use disorder (excluding nicotine or caffeine)~15. Subjects who require concomitant treatment with prohibited medication, as specified in Attachment 2

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- 1 Hz rTMS Stimulation first, then 20 Hz rTMS Stimulation, then sham rTMS (Type: EXPERIMENTAL): Subjects will receive one session of each: low frequency rTMS within the following stimulation parameters: Continuous 20-minute train of 1 Hz rTMS, at 120% of motor threshold (MT), for a total of 1200 pulses, high frequency rTMS within the following stimulation parameters: 20 Hz, at 120% of MT, 60 trains (1.0 second per train), 20 pulses per train, inter-train interval of 15 seconds, for a total of 1200 pulses over 16 minute, Sham stimulation session targeting the precuneus. The active and sham functions share the same acoustic properties and sham mimics cutaneous stimulation, facilitating double-blinding.
- 1 Hz rTMS Stimulation first, then sham rTMS, then 20 Hz rTMS Stimulation (Type: EXPERIMENTAL): Subjects will receive one session of each: low frequency rTMS within the following stimulation parameters: Continuous 20-minute train of 1 Hz rTMS, at 120% of motor threshold (MT), for a total of 1200 pulses, high frequency rTMS within the following stimulation parameters: 20 Hz, at 120% of MT, 60 trains (1.0 second per train), 20 pulses per train, inter-train interval of 15 seconds, for a total of 1200 pulses over 16 minute, Sham stimulation session targeting the precuneus. The active and sham functions share the same acoustic properties and sham mimics cutaneous stimulation, facilitating double-blinding.
- 20 Hz rTMS Stimulation first, then 1 Hz rTMS Stimulation, then sham rTMS (Type: EXPERIMENTAL): Subjects will receive one session of each: low frequency rTMS within the following stimulation parameters: Continuous 20-minute train of 1 Hz rTMS, at 120% of motor threshold (MT), for a total of 1200 pulses, high frequency rTMS within the following stimulation parameters: 20 Hz, at 120% of MT, 60 trains (1.0 second per train), 20 pulses per train, inter-train interval of 15 seconds, for a total of 1200 pulses over 16 minute, Sham stimulation session targeting the precuneus. The active and sham functions share the same acoustic properties and sham mimics cutaneous stimulation, facilitating double-blinding.
- 20 Hz rTMS Stimulation first, then sham rTMS, then 1 Hz rTMS Stimulation (Type: EXPERIMENTAL): Subjects will receive one session of each: low frequency rTMS within the following stimulation parameters: Continuous 20-minute train of 1 Hz rTMS, at 120% of motor threshold (MT), for a total of 1200 pulses, high frequency rTMS within the following stimulation parameters: 20 Hz, at 120% of MT, 60 trains (1.0 second per train), 20 pulses per train, inter-train interval of 15 seconds, for a total of 1200 pulses over 16 minute, Sham stimulation session targeting the precuneus. The active and sham functions share the same acoustic properties and sham mimics cutaneous stimulation, facilitating double-blinding.
- sham rTMS first, then 1 Hz rTMS Stimulation, then 20 Hz rTMS Stimulation (Type: EXPERIMENTAL): Subjects will receive one session of each: low frequency rTMS within the following stimulation parameters: Continuous 20-minute train of 1 Hz rTMS, at 120% of motor threshold (MT), for a total of 1200 pulses, high frequency rTMS within the following stimulation parameters: 20 Hz, at 120% of MT, 60 trains (1.0 second per train), 20 pulses per train, inter-train interval of 15 seconds, for a total of 1200 pulses over 16 minute, Sham stimulation session targeting the precuneus. The active and sham functions share the same acoustic properties and sham mimics cutaneous stimulation, facilitating double-blinding.
- sham rTMS first, then 20 Hz rTMS Stimulation, then 1 Hz rTMS Stimulation (Type: EXPERIMENTAL): Subjects will receive one session of each: low frequency rTMS within the following stimulation parameters: Continuous 20-minute train of 1 Hz rTMS, at 120% of motor threshold (MT), for a total of 1200 pulses, high frequency rTMS within the following stimulation parameters: 20 Hz, at 120% of MT, 60 trains (1.0 second per train), 20 pulses per train, inter-train interval of 15 seconds, for a total of 1200 pulses over 16 minute, Sham stimulation session targeting the precuneus. The active and sham functions share the same acoustic properties and sham mimics cutaneous stimulation, facilitating double-blinding.

Based on this trial design, predict the completion outcome and termination type (if applicable).